Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

During the Trading Day
21.35 +0.42 / +2.01%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
21.23 -0.1191 / -0.56%
 
Volume: 1.2K
No recent news for Repligen Corp.

Today’s Trading

Previous close20.93
Today’s open20.75
Day’s range20.07 - 22.12
Volume201,298
Average volume (3 months)381,971
Market cap$689.5M
Dividend yield--
Data as of 4:00pm ET, 02/09/2016

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)+36.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-6.78%
P/E ratio82.8
Price/Sales10.36
Price/Book6.14

Competitors

 Today’s
change
Today’s
% change
CLLSCellectis SA-0.68-3.50%
CLVSClovis Oncology Inc-0.25-1.33%
DERMDermira Inc+0.14+0.58%
DVAXDynavax Technologies...-0.62-3.29%
Data as of 4:00pm ET, 02/09/2016

Financials

Next reporting dateMarch 11, 2016
EPS forecast (this quarter)$0.07
Annual revenue (last year)$63.5M
Annual profit (last year)$8.2M
Net profit margin12.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Operating Officer
Tony J. Hunt
Chief Financial Officer
Jon K. Snodgres
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers